Citation 11651

TANIGUCHI,S: IMAYOSHI,Y: KOBAYASHI,E: TAKAMATSU,Y: ITO,H: HATANO,T: SAKAGAMI,H: TOKUDA,H: NISHINO,H: SUGITA,D: SHIMURA,S: YOSHIDA,T:. (2002). PRODUCTION OF BIOACTIVE TRITERPENES BY ERIOBOTRYA JAPONICA CALLI.. 59(3)

Citation Details

Title	PRODUCTION OF BIOACTIVE TRITERPENES BY ERIOBOTRYA JAPONICA CALLI.
Authors	TANIGUCHI,S: IMAYOSHI,Y: KOBAYASHI,E: TAKAMATSU,Y: ITO,H: HATANO,T: SAKAGAMI,H: TOKUDA,H: NISHINO,H: SUGITA,D: SHIMURA,S: YOSHIDA,T:
Year	2002
Volume	59
Issue	3

Summary

Year: 2002

Journal: Unknown

Organisms and Their Experiments (1)

Eriobotrya japonica (ROSACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	Not specified	ISOLATION AND IDENTIFICATION OFPLANT TISSUE CULTURE MARKER CODE	URSOLIC ACID	None
2	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	EQUIVOCAL
3	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	EQUIVOCAL
4	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	WEAK ACTIVITY
5	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	URSOLIC ACID	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	INACTIVE
7	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	INACTIVE
8	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	INACTIVE
9	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	ACTIVE
10	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	WEAK ACTIVITY
11	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	WEAK ACTIVITY
12	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	WEAK ACTIVITY
13	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	INACTIVE
14	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	WEAK ACTIVITY
15	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	EQUIVOCAL
16	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	WEAK ACTIVITY
17	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	ACTIVE
18	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	INACTIVE
19	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	INACTIVE
20	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	INACTIVE
21	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	WEAK ACTIVITY
22	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	WEAK ACTIVITY
23	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	WEAK ACTIVITY
24	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	OLEANOLIC ACIDTORMENTIC ACIDMASLINIC ACIDCORSOLIC ACID	INACTIVE
25	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	ACTIVE
26	ANTITUMOR ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	ACTIVE
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	WEAK ACTIVITY
28	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	WEAK ACTIVITY
29	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	EQUIVOCAL
30	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	ACTIVE
31	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	WEAK ACTIVITY
32	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	EQUIVOCAL
33	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	EQUIVOCAL
34	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	ACTIVE
35	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	WEAK ACTIVITY
36	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	EQUIVOCAL
37	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	EQUIVOCAL
38	EPSTEIN-BARR VIRUS EARLY ANTIGEN ACTIVATION INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	TORMENTIC ACID,3-O-CIS-PARA-COUMAROYL:TORMENTIC ACID,3-O-TRANS-PARA-COUMAROYL:HYPTADIENIC ACIDURS-12-EN-28-OIC ACID,2-ALPHA-19-ALPHA-DIHYDROXY-3-OXO:	ACTIVE

Citation 11651

Citation Details

Summary

Organisms and Their Experiments (1)

Eriobotrya japonica (ROSACEAE)

Show SPARQL Queries (1)

Query 1